JP2025124718A5 - - Google Patents
Info
- Publication number
- JP2025124718A5 JP2025124718A5 JP2025084749A JP2025084749A JP2025124718A5 JP 2025124718 A5 JP2025124718 A5 JP 2025124718A5 JP 2025084749 A JP2025084749 A JP 2025084749A JP 2025084749 A JP2025084749 A JP 2025084749A JP 2025124718 A5 JP2025124718 A5 JP 2025124718A5
- Authority
- JP
- Japan
- Prior art keywords
- kalbtg
- recognition site
- seq
- modified antibody
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217585.5 | 2021-12-23 | ||
| EP21217585.5A EP4201956A1 (en) | 2021-12-23 | 2021-12-23 | Kutzneria albida (kalbtg) transglutaminase used for antibody conjugations |
| JP2022206731A JP7686613B2 (ja) | 2021-12-23 | 2022-12-23 | 部位特異的抗体コンジュゲーション及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022206731A Division JP7686613B2 (ja) | 2021-12-23 | 2022-12-23 | 部位特異的抗体コンジュゲーション及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025124718A JP2025124718A (ja) | 2025-08-26 |
| JP2025124718A5 true JP2025124718A5 (https=) | 2026-01-29 |
Family
ID=80119611
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022206731A Active JP7686613B2 (ja) | 2021-12-23 | 2022-12-23 | 部位特異的抗体コンジュゲーション及びその使用 |
| JP2025084749A Pending JP2025124718A (ja) | 2021-12-23 | 2025-05-21 | 部位特異的抗体コンジュゲーション及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022206731A Active JP7686613B2 (ja) | 2021-12-23 | 2022-12-23 | 部位特異的抗体コンジュゲーション及びその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230310641A1 (https=) |
| EP (2) | EP4201956A1 (https=) |
| JP (2) | JP7686613B2 (https=) |
| KR (1) | KR20240118825A (https=) |
| CN (1) | CN118434763A (https=) |
| AU (1) | AU2022418204A1 (https=) |
| CA (1) | CA3242447A1 (https=) |
| CL (1) | CL2024001920A1 (https=) |
| CO (1) | CO2024008389A2 (https=) |
| CR (1) | CR20240256A (https=) |
| IL (1) | IL313340A (https=) |
| MX (1) | MX2024007648A (https=) |
| PE (1) | PE20251186A1 (https=) |
| WO (1) | WO2023118398A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025032071A1 (en) | 2023-08-09 | 2025-02-13 | F. Hoffmann-La Roche Ag | Mono and multispecific anti-trem2 antibodies, methods and uses thereof |
| AU2024323186A1 (en) | 2023-08-09 | 2026-01-15 | F. Hoffmann-La Roche Ag | Mono and multispecific anti-trem2 antibodies, methods and uses thereof |
| WO2025157804A1 (en) | 2024-01-24 | 2025-07-31 | F. Hoffmann-La Roche Ag | Linkers for site-specific protein conjugation |
| WO2025215060A1 (en) | 2024-04-11 | 2025-10-16 | F. Hoffmann-La Roche Ag | Antibodies that specifically bind modified oligonucleotides |
| WO2026037757A1 (en) * | 2024-08-13 | 2026-02-19 | F. Hoffmann-La Roche Ag | Modified aav particles |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9676871B2 (en) * | 2010-11-05 | 2017-06-13 | Pfizer Inc. | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| US11054425B2 (en) * | 2014-12-19 | 2021-07-06 | Roche Sequencing Solutions, Inc. | System and method for identification and characterization of transglutaminase species |
| ES2871624T3 (es) | 2014-12-19 | 2021-10-29 | Hoffmann La Roche | Transglutaminasas microbianas, sustratos para las mismas y procedimientos para el uso de las mismas |
| KR102943992B1 (ko) | 2015-12-15 | 2026-03-25 | 에프. 호프만-라 로슈 아게 | 트랜스글루타미나제 인식 부위를 갖는 fkbp 도메인 |
| KR20210102334A (ko) * | 2018-12-12 | 2021-08-19 | 브리스톨-마이어스 스큅 컴퍼니 | 트랜스글루타미나제 접합을 위해 변형된 항체, 그의 접합체, 및 방법 및 용도 |
| BR112022017136A2 (pt) | 2020-02-28 | 2022-10-11 | Tallac Therapeutics Inc | Conjugação mediada por transglutaminase |
-
2021
- 2021-12-23 EP EP21217585.5A patent/EP4201956A1/en not_active Withdrawn
-
2022
- 2022-12-22 KR KR1020247022190A patent/KR20240118825A/ko active Pending
- 2022-12-22 CA CA3242447A patent/CA3242447A1/en active Pending
- 2022-12-22 IL IL313340A patent/IL313340A/en unknown
- 2022-12-22 WO PCT/EP2022/087399 patent/WO2023118398A1/en not_active Ceased
- 2022-12-22 CN CN202280085397.1A patent/CN118434763A/zh active Pending
- 2022-12-22 CR CR20240256A patent/CR20240256A/es unknown
- 2022-12-22 PE PE2024001457A patent/PE20251186A1/es unknown
- 2022-12-22 EP EP22844060.8A patent/EP4405388A1/en active Pending
- 2022-12-22 MX MX2024007648A patent/MX2024007648A/es unknown
- 2022-12-22 AU AU2022418204A patent/AU2022418204A1/en active Pending
- 2022-12-22 US US18/145,453 patent/US20230310641A1/en active Pending
- 2022-12-23 JP JP2022206731A patent/JP7686613B2/ja active Active
-
2024
- 2024-06-21 CL CL2024001920A patent/CL2024001920A1/es unknown
- 2024-06-26 CO CONC2024/0008389A patent/CO2024008389A2/es unknown
-
2025
- 2025-05-21 JP JP2025084749A patent/JP2025124718A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025124718A5 (https=) | ||
| JP7457764B2 (ja) | ヘテロ二量体多重特異性抗体フォーマット | |
| US12344679B2 (en) | CH3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof | |
| Kontermann et al. | Bispecific antibodies | |
| CN110382529B (zh) | 工程化的异源二聚体蛋白质 | |
| JP7356726B2 (ja) | タンパク性ヘテロ二量体及びその使用 | |
| JP2023123649A5 (https=) | ||
| CN105229036A (zh) | 在疏水性相互作用位点内引入了静电相互作用的蛋白及其制备方法 | |
| JP2024504777A (ja) | Ｍｕｌｔａｂｏｄｙ構築物、組成物および方法 | |
| JPWO2020247871A5 (https=) | ||
| JPWO2022102768A5 (https=) | ||
| JP2022545234A (ja) | Ｃｄ３とｃｄ２０を標的とする二重特異性抗体及びその使用 | |
| WO2020192648A1 (en) | Proteinaceous heterodimer and use thereof | |
| RU2024120045A (ru) | Сайт-специфическая конъюгация антител и ее применение | |
| JPWO2023056252A5 (https=) | ||
| WO2024017281A1 (zh) | 多特异性抗体及其用途 | |
| JPWO2022183074A5 (https=) | ||
| JPWO2022073138A5 (https=) | ||
| WO2025167974A1 (zh) | 多特异性抗体或抗原结合片段 | |
| JP2025528101A (ja) | 多重特異性ポリペプチド複合体 | |
| HK40128069A (zh) | 包括双特异性型式的针对紧密连接蛋白6的抗体 | |
| HK40079873A (en) | Hetero-dimeric multi-specific antibody format | |
| EA041608B1 (ru) | Гетеродимерный полиспецифичный формат антител | |
| JPWO2023060358A5 (https=) |